BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19174478)

  • 1. MeCP2 involvement in the regulation of neuronal alpha-tubulin production.
    Abuhatzira L; Shemer R; Razin A
    Hum Mol Genet; 2009 Apr; 18(8):1415-23. PubMed ID: 19174478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MeCP2 dysfunction in Rett syndrome and related disorders.
    Moretti P; Zoghbi HY
    Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
    Kaufmann WE; Johnston MV; Blue ME
    Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome.
    Moretti P; Bouwknecht JA; Teague R; Paylor R; Zoghbi HY
    Hum Mol Genet; 2005 Jan; 14(2):205-20. PubMed ID: 15548546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation.
    Belichenko NP; Belichenko PV; Mobley WC
    Neurobiol Dis; 2009 Apr; 34(1):71-7. PubMed ID: 19167498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
    Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
    Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rett syndrome: of girls and mice--lessons for regression in autism.
    Glaze DG
    Ment Retard Dev Disabil Res Rev; 2004; 10(2):154-8. PubMed ID: 15362175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The story of Rett syndrome: from clinic to neurobiology.
    Chahrour M; Zoghbi HY
    Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MeCP2 deficiency is associated with impaired microtubule stability.
    Delépine C; Nectoux J; Bahi-Buisson N; Chelly J; Bienvenu T
    FEBS Lett; 2013 Jan; 587(2):245-53. PubMed ID: 23238081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
    Gadalla KK; Bailey ME; Cobb SR
    Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MeCP2 in neurons: closing in on the causes of Rett syndrome.
    Caballero IM; Hendrich B
    Hum Mol Genet; 2005 Apr; 14 Spec No 1():R19-26. PubMed ID: 15809268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome.
    Schmid RS; Tsujimoto N; Qu Q; Lei H; Li E; Chen T; Blaustein CS
    Neuroreport; 2008 Mar; 19(4):393-8. PubMed ID: 18287934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks.
    Belichenko PV; Wright EE; Belichenko NP; Masliah E; Li HH; Mobley WC; Francke U
    J Comp Neurol; 2009 May; 514(3):240-58. PubMed ID: 19296534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome.
    Asaka Y; Jugloff DG; Zhang L; Eubanks JH; Fitzsimonds RM
    Neurobiol Dis; 2006 Jan; 21(1):217-27. PubMed ID: 16087343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rett syndrome: from the gene to the disease.
    Matijevic T; Knezevic J; Slavica M; Pavelic J
    Eur Neurol; 2009; 61(1):3-10. PubMed ID: 18948693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.
    Gold WA; Lacina TA; Cantrill LC; Christodoulou J
    J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of disease: neurogenetics of MeCP2 deficiency.
    Francke U
    Nat Clin Pract Neurol; 2006 Apr; 2(4):212-21. PubMed ID: 16932552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells.
    Jung BP; Jugloff DG; Zhang G; Logan R; Brown S; Eubanks JH
    J Neurobiol; 2003 Apr; 55(1):86-96. PubMed ID: 12605461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered microtubule dynamics in Mecp2-deficient astrocytes.
    Nectoux J; Florian C; Delepine C; Bahi-Buisson N; Khelfaoui M; Reibel S; Chelly J; Bienvenu T
    J Neurosci Res; 2012 May; 90(5):990-8. PubMed ID: 22252744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.